Sermo

Leading physician-only social network and healthcare insights platform globally

Sermo operates as the world's largest social network exclusively for verified physicians, connecting over 1.3 million doctors across 150 countries. The platform enables physicians to discuss clinical cases, share medical knowledge, and engage in peer-to-peer collaboration while maintaining anonymity. Beyond its community function, Sermo serves as a critical healthcare insights platform for pharmaceutical companies, medical device manufacturers, and healthcare market researchers who seek real-time physician feedback, conduct surveys, and gather market intelligence directly from practicing doctors. Founded in 2005 and acquired by Citeline (a portfolio company of Warburg Pincus) in 2022, Sermo continues to operate as a distinct brand and platform. The company bridges the gap between the medical community and the pharmaceutical industry, offering pharmaceutical companies access to physician opinions on drug development, treatment protocols, and market trends. While primarily positioned in the healthcare market research and physician engagement space rather than traditional advertising technology, Sermo's platform enables targeted physician outreach and engagement that serves marketing and research objectives for life sciences companies. Sermo's dual-sided platform creates value by providing physicians with CME credits, compensation for survey participation, and professional networking opportunities, while offering pharmaceutical and healthcare companies unprecedented access to physician insights and engagement at scale. The platform has become an essential tool for understanding physician perspectives on new therapies, competitive landscapes, and treatment adoption patterns in real-time.